Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly

Bing Z Carter1, Yi Hua Qiu, Nianxiang Zhang

  • 1Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

Blood
|November 3, 2010
PubMed

Insights

High levels of Apoptosis Repressor with Caspase Recruitment Domain (ARC) protein are linked to poorer outcomes in acute myeloid leukemia (AML). Lower ARC levels indicate better survival and remission duration in AML patients, suggesting ARC as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Regulators of apoptosis are key therapeutic targets in acute myeloid leukemia (AML).
  • Apoptosis Repressor with Caspase Recruitment Domain (ARC), an antiapoptotic protein, is overexpressed in various cancers.

Purpose of the Study:

  • To investigate the prognostic significance of ARC protein expression in newly diagnosed AML patients.
  • To evaluate ARC as a potential therapeutic target in AML.

Main Methods:

  • ARC protein expression was profiled in 511 AML patients using reverse-phase protein array.
  • ARC levels were correlated with clinical outcomes, including overall survival and remission duration.
  • Inhibition of ARC was studied in OCI-AML3 cells to assess its effect on apoptosis.

Main Results:

  • ARC was variably expressed in AML samples and not associated with cytogenetic groups or FLT-3 mutation status.
  • Patients with low or medium ARC levels showed significantly longer overall survival and remission duration compared to those with high ARC levels.
  • Multivariate analysis confirmed ARC as an independent predictor of survival in AML (P = .00013).
  • ARC inhibition promoted apoptosis and sensitized AML cells to chemotherapy.

Conclusions:

  • ARC protein levels are a significant prognostic marker in AML.
  • ARC represents a potential therapeutic target for improving AML patient outcomes.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...